SenesTech, Inc. (SNES)
| Market Cap | 8.69M +77.9% |
| Revenue (ttm) | 2.23M +15.7% |
| Net Income | -6.78M |
| EPS | -1.59 |
| Shares Out | 5.27M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 26,130 |
| Open | 1.720 |
| Previous Close | 1.690 |
| Day's Range | 1.600 - 1.720 |
| 52-Week Range | 1.410 - 6.240 |
| Beta | 0.29 |
| Analysts | Strong Buy |
| Price Target | 6.75 (+309.09%) |
| Earnings Date | May 12, 2026 |
About SNES
SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption. It also develops Evolve Mouse, a modified version of its bait technology containing the act... [Read more]
Financial Performance
In 2025, SenesTech's revenue was $2.22 million, an increase of 19.60% compared to the previous year's $1.86 million. Losses were -$6.38 million, 3.22% more than in 2024.
Financial StatementsAnalyst Summary
According to one analyst, the rating for SNES stock is "Strong Buy" and the 12-month stock price target is $6.75.
News
SenesTech expands distribution of Evolve Rodent Birth Control into Bermuda
SenesTech (SNES) announced the expansion of its Evolve Rodent Birth Control products into Bermuda through a distribution agreement with Animal and Garden House. Other existing and expanding deployment...
SenesTech Expands Distribution of Evolve® Rodent Birth Control™ into Bermuda
SURPRISE, Ariz., June 4, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in birth control solutions for managing rodent populations, today announced the expansion of its Evolve® Rodent B...
SenesTech Proxy statement: Proxy filing
SenesTech filed a proxy statement on June 4, 2026, providing details for shareholder voting and corporate governance matters.
SenesTech Announces Amendment to Equity Incentive Plan Proposal
PHOENIX, June 3, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) ("SenesTech" or the "Company"), today announced that its Board of Directors has approved an amendment to the proposed changes to th...
SenesTech Proxy statement: Proxy filing
SenesTech filed a proxy statement on June 3, 2026, providing details for shareholder voting and corporate governance matters.
SenesTech Transcript: Lytham Partners Spring 2026 Investor Conference
A new CEO with deep consumer products experience is leading a strategic shift to prioritize direct-to-consumer growth, recurring revenue, and brand awareness, while revamping B2B approaches for targeted verticals. Operational improvements and a focus on profitability and accountability are expected to drive measurable progress.
SenesTech Proxy statement: Proxy filing
SenesTech filed a proxy statement on May 27, 2026, providing details for shareholder voting and corporate governance matters.
SenesTech to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
SURPRISE, Ariz., May 19, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Bir...
SenesTech reports Q1 EPS (39c) vs. ($1.28) last year
Reports Q1 revenue $493,000 vs. $485,000 last year. “SenesTech (SNES) is entering a new phase where we are building a more scalable, data-driven and recurring revenue business model around the…
SenesTech Earnings Call Transcript: Q1 2026
Q1 2026 saw record growth in direct-to-consumer, subscription, and B2B revenues, with gross margin reaching 68.6%. Strategic shifts to in-house Amazon management and a focus on recurring revenue are driving momentum, and management expects continued quarter-over-quarter growth.
SenesTech Earnings release: Q1 2026
SenesTech released its Q1 2026 earnings on May 12, 2026, summarizing the period's financial results.
SenesTech Quarterly report: Q1 2026
SenesTech has published its Q1 2026 quarterly earnings report on May 12, 2026.
SenesTech Reports Record Direct-to-Consumer and Subscription Growth Following Strategic E-Commerce Transition
In-house e-commerce transition and new CEO expected to support scalable recurring revenue growth strategy SURPRISE, Ariz., May 12, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fe...
SenesTech names Michael Edell as President and CEO
SenesTech (SNES) announced the appointment of Michael Edell as President and CEO, effective May 6. The company also announced Board leadership transition updates to support SenesTech’s next phase of c...
SenesTech to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026
Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern time PHOENIX, May 7, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertil...
SenesTech Appoints Michael Edell as President and Chief Executive Officer to Drive Revenue Growth and Scalable Sales Channels
SURPRISE, Ariz., May 7, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a leader in humane pest control solutions, today announced the appointment of Michael Edell a...
SenesTech Proxy statement: Proxy filing
SenesTech filed a proxy statement on May 7, 2026, providing details for shareholder voting and corporate governance matters.
SenesTech Proxy statement: Proxy filing
SenesTech filed a proxy statement on April 29, 2026, providing details for shareholder voting and corporate governance matters.
SenesTech Proxy statement: Proxy filing
SenesTech filed a proxy statement on April 29, 2026, providing details for shareholder voting and corporate governance matters.
SenesTech Earnings Call Transcript: Q4 2025
Revenue grew 20% to $2.2M in 2025, with e-commerce up 88% and gross margin rising to 62.5%. Adjusted net loss improved, and the company resolved major litigation, expanded internationally, and is targeting accelerated growth in 2026.
SenesTech Annual report: Q4 2025
SenesTech has published its Q4 2025 annual report on March 12, 2026.
SenesTech Earnings release: Q4 2025
SenesTech released its Q4 2025 earnings on March 12, 2026, summarizing the period's financial results.
SenesTech reports Q4 EPS (35c) vs. ($1.22) last year
Reports Q4 revenue $421M vs. $501M last year. Cash and short-term investments of $8.6M at the end of 2025 are believed to be sufficient to provide operating runway through approximately…
SenesTech Announces 2025 Financial Results Driven by Strong Growth in E-Commerce
SURPRISE, Ariz., March 12, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in birth control solutions for managing rodent populations, today announced financial results for the fourth qu...
SenesTech to Report Fourth Quarter and Fiscal Year 2025 Financial Results on Thursday, March 12, 2026
Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern time PHOENIX, March 9, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in birth ...